RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Resources Pharmaceutical Group Stock

China Resources Pharmaceutical Group P/S 2024

China Resources Pharmaceutical Group P/S

0.13

Ticker

3320.HK

ISIN

HK0000311099

WKN

A2ATTU

As of Sep 16, 2024, China Resources Pharmaceutical Group's P/S ratio stood at 0.13, a -31.58% change from the 0.19 P/S ratio recorded in the previous year.

The China Resources Pharmaceutical Group P/S history

China Resources Pharmaceutical Group Aktienanalyse

What does China Resources Pharmaceutical Group do?

China Resources Pharmaceutical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding China Resources Pharmaceutical Group's P/S Ratio

China Resources Pharmaceutical Group's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing China Resources Pharmaceutical Group's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating China Resources Pharmaceutical Group's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in China Resources Pharmaceutical Group’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about China Resources Pharmaceutical Group stock

What is the price-to-earnings ratio of China Resources Pharmaceutical Group?

The price-earnings ratio of China Resources Pharmaceutical Group is currently 0.13.

How has the price-earnings ratio of China Resources Pharmaceutical Group changed compared to last year?

The price-to-earnings ratio of China Resources Pharmaceutical Group has increased by -31.58% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of China Resources Pharmaceutical Group high compared to other companies?

Yes, the price-to-earnings ratio of China Resources Pharmaceutical Group is high compared to other companies.

How does an increase in the price-earnings ratio of China Resources Pharmaceutical Group affect the company?

An increase in the price-earnings ratio of China Resources Pharmaceutical Group would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of China Resources Pharmaceutical Group affect the company?

A decrease in the price-earnings ratio of China Resources Pharmaceutical Group would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of China Resources Pharmaceutical Group?

Some factors that influence the price-earnings ratio of China Resources Pharmaceutical Group are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does China Resources Pharmaceutical Group pay?

Over the past 12 months, China Resources Pharmaceutical Group paid a dividend of 0.16 CNY . This corresponds to a dividend yield of about 3.63 %. For the coming 12 months, China Resources Pharmaceutical Group is expected to pay a dividend of 0.17 CNY.

What is the dividend yield of China Resources Pharmaceutical Group?

The current dividend yield of China Resources Pharmaceutical Group is 3.63 %.

When does China Resources Pharmaceutical Group pay dividends?

China Resources Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of July, July, October, October.

How secure is the dividend of China Resources Pharmaceutical Group?

China Resources Pharmaceutical Group paid dividends every year for the past 12 years.

What is the dividend of China Resources Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.17 CNY are expected. This corresponds to a dividend yield of 3.84 %.

In which sector is China Resources Pharmaceutical Group located?

China Resources Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Resources Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Resources Pharmaceutical Group from 10/30/2024 amounting to 0.01 CNY, you needed to have the stock in your portfolio before the ex-date on 9/12/2024.

When did China Resources Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 10/30/2024.

What was the dividend of China Resources Pharmaceutical Group in the year 2023?

In the year 2023, China Resources Pharmaceutical Group distributed 0.15 CNY as dividends.

In which currency does China Resources Pharmaceutical Group pay out the dividend?

The dividends of China Resources Pharmaceutical Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Resources Pharmaceutical Group

Our stock analysis for China Resources Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Resources Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.